Aerosolic Application of Phages Against S. infantis on Plates and Chicken Skin

Lisa Winkelmayer1, Krista Rathammer1, Susanne Richter1

  • 1Austrian Agency for Health and Food Safety, Vienna, Austria.

PubMed

Insights

Phage therapy shows promise for combating antimicrobial resistance (AMR). This study demonstrates that nebulized phage particles can effectively infect Salmonella, suggesting potential for aerosolized phage applications.

Area of Science:

  • Microbiology and Virology
  • Antimicrobial Resistance (AMR) Research
  • Bacteriophage Applications

Background:

  • Bacteriophages (phages) are viruses that infect bacteria and are a potential alternative to antibiotics for combating antimicrobial resistance (AMR).
  • Expanding phage therapy applications requires evaluating methods like aerosolization, which necessitates understanding phage infectivity post-nebulization.

Purpose of the Study:

  • To assess the infectivity and efficacy of nebulized phage particles against Salmonella infantis.
  • To evaluate the potential of using commercial nebulizers for aerosolized phage delivery in combating bacterial infections.

Main Methods:

  • Salmonella infantis cultures on plates and chicken skin were treated with nebulized Myoviridae phage particles.
  • A commercial nebulizer, typically used for hydrogen peroxide disinfection, was employed for phage aerosolization.
  • Transmission electron microscopy was used for phage identification, and bacterial reduction was quantified.

Main Results:

  • Nebulized phage particles demonstrated the ability to infect Salmonella infantis.
  • Aerosol-applied phages successfully reduced bacterial numbers on both plate cultures and chicken skin.
  • Ultrasound technology within the nebulizer facilitated effective phage delivery and subsequent bacterial infection.

Conclusions:

  • Aerosolized phage particles retain infectivity and efficacy against Salmonella, supporting their potential use in combating bacterial infections.
  • Commercial nebulizers can be adapted for phage aerosol delivery, broadening therapeutic application possibilities.
  • Further research is needed to standardize aerosolized phage application protocols for different phage types and conditions.